Form 4: Omada Health Insider Trades: Stock Option Activity

Omada Health's Chief Accounting Officer, Craig Gracey, executed trades involving stock options and common stock under a Rule 10b5-1 plan.

Summary

• Craig Gracey, Chief Accounting Officer at Omada Health, Inc., reported transactions involving common stock and stock options.
• On June 30, 2026, Gracey acquired 405 shares of common stock at $6.57 per share and disposed of 405 shares at $22 per share.
• On July 1, 2026, Gracey acquired an additional 637 shares of common stock at $6.57 per share and disposed of 637 shares at $23 per share.
• These transactions were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.
• The filing also details the vesting schedule for stock options, with 25% vesting on the first anniversary of September 9, 2024, and the remainder vesting monthly over the subsequent 48 months.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions executed under a pre-established plan, with no immediate indication of significant positive or negative company performance.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 plan, indicating a structured and pre-determined trading strategy.
• The acquisition of shares at a lower price ($6.57) and disposal at a higher price ($22-$23) suggests a profitable execution of the plan for the reporting person.

Negatives

• The disposal of shares at a significantly higher price than the acquisition price indicates a sale of equity, which could be interpreted as a reduction in direct beneficial ownership.
• The difference between the acquisition price of the stock options ($6.57) and the disposal price of the common stock ($22-$23) highlights a substantial gain realized by the reporting person.

Risks

• The disposal of shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market if it suggests a lack of confidence in future price appreciation, although this is mitigated by the plan's nature.
• The vesting schedule for stock options indicates a phased release of equity, meaning a significant portion of potential future ownership is still subject to time-based vesting.

Future Outlook

The filing details the vesting schedule for stock options, indicating that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date (September 9, 2024).

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by Omada Health's Chief Accounting Officer is a common practice to pre-arrange stock sales or purchases, providing a defense against accusations of insider trading. The specific details of the plan and the executed trades offer insight into the reporting person's financial strategy.

Stakeholder Impact

• Shareholders: The disposal of shares by a key executive might be monitored, but the use of a 10b5-1 plan mitigates concerns about insider trading. The profit realized by the executive is a personal financial matter.
• Employees: The vesting schedule for stock options impacts employees who hold these options, providing a clear timeline for potential equity realization.
• Management: The transactions reflect the financial planning of a senior executive.

Next Steps

• Continued vesting of stock options according to the schedule outlined.
• Potential future transactions under the Rule 10b5-1 plan, if applicable and continued.

Key Dates

Keywords

Form 4, SEC Filing, Omada Health, OMDA, Insider Trading, Stock Options, Common Stock, 10b5-1 Plan, Beneficial Ownership, Craig Gracey, Chief Accounting Officer